Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus: Effect on carotid intima-media thickness
Zeitschrift fur Rheumatologie, Volume 72, No. 2, Year 2013
Notification
URL copied to clipboard!
Description
Objective: The aim of the present study was to assess the effect of metabolic syndrome (MetS) and insulin resistance comorbidity on the carotid intima-media thickness (IMT) in systemic lupus erythematosus (SLE) patients and their relationship to clinical manifestations, disease activity, and damage. Methods: The study included 92 SLE patients (mean age 30.18 ± 8.27 years) and 30 matched controls. Disease activity and damage were assessed by the SLEDAI and SLICC indices, respectively. The Health Assessment Questionnaire II (HAQII) and Quality of Life (QoL) index were evaluated in the patients. Levels of insulin, glucose, and creatinine and the lipid profile were measured in patients and controls. Insulin sensitivity was estimated using the homeostatic model assessment index (HOMA-B) for beta cell function and (HOMA-IR) for peripheral tissue insulin resistance. The carotid IMT was measured by ultrasonography. Results: The SLE patients had high HOMA-IR and HOMA-B. The IMT was significantly increased (0.82± 0.29 mm) compared to the controls (0.45± 0.2 mm).The HOMA-IR, SLEDAI, SLICC, HAQII, and IMT were significantly higher and the QoL lower in those with MetS (n = 34) compared to those without (n = 58), while the HOMAB was comparable. There was a significant correlation between the IMT and the SLEDAI, SLICC, and WHR. Conclusion: Insulin sensitivity and IMT are altered in SLE patients, especially those with MetS comorbidity with an associated increase in disease activity and damage. Effective management of MetS would help control SLE activity, damage, and the future development of cardiovascular events especially in the absence of symptoms of cardiovascular disease. © 2012 Springer-Verlag Berlin Heidelberg.
Authors & Co-Authors
A Gheita, Tamer
Egypt, Cairo
Faculty of Medicine
Raafat, Hala Ahmed
Egypt, Cairo
Faculty of Medicine
Sayed, Safaa Y.
Egypt, Cairo
Faculty of Medicine
El-Fishawy, Hussein Saeed
Egypt, Cairo
Faculty of Medicine
Nasrallah, Mohamed M.
Egypt, Cairo
Faculty of Medicine
Abdel-Rasheed, Enas
Egypt, Giza
National Research Centre
Statistics
Citations: 49
Authors: 6
Affiliations: 2
Identifiers
Doi:
10.1007/s00393-012-1058-9
ISSN:
03401855
Research Areas
Disability
Noncommunicable Diseases